1. Home
  2. TGTX vs SKY Comparison

TGTX vs SKY Comparison

Compare TGTX & SKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$30.63

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

SKY

Skyline Champion Corporation

HOLD

Current Price

$93.11

Market Cap

4.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGTX
SKY
Founded
1993
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.8B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
TGTX
SKY
Price
$30.63
$93.11
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$50.67
$101.00
AVG Volume (30 Days)
1.4M
847.7K
Earning Date
05-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
66.67
35.18
EPS
2.62
3.12
Revenue
$2,785,000.00
$2,483,448,000.00
Revenue This Year
$90.97
$7.75
Revenue Next Year
$45.74
$3.48
P/E Ratio
$11.32
$29.66
Revenue Growth
N/A
22.65
52 Week Low
$25.37
$59.44
52 Week High
$46.48
$103.93

Technical Indicators

Market Signals
Indicator
TGTX
SKY
Relative Strength Index (RSI) 58.00 53.90
Support Level $29.81 $73.46
Resistance Level $33.05 $95.38
Average True Range (ATR) 1.14 3.51
MACD 0.23 0.28
Stochastic Oscillator 87.33 65.65

Price Performance

Historical Comparison
TGTX
SKY

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

About SKY Skyline Champion Corporation

Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.

Share on Social Networks: